Michael Tee

The gut microbiota and host health: a new clinical frontier

Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases

Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis

Rheumatoid arthritis

mRNA vaccines — a new era in vaccinology

Rheumatoid arthritis

European evidence based consensus for endoscopy in inflammatory bowel disease

Emerging concepts of type I interferons in SLE pathogenesis and therapy

Crohn's disease

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

Ulcerative colitis

The role of biosimilars in the treatment of rheumatic diseases

Proposal for a new nomenclature of disease-modifying antirheumatic drugs

Hidradenitis suppurativa

Ulcerative colitis

The changing landscape of biosimilars in rheumatology

TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants – past, present and future

Comparable long-term efficacy, as assessed by patient-reported outcomes, safety and pharmacokinetics, of CT-P13 and reference infliximab in patients with ankylosing spondylitis: 54-week results from the randomized, parallel-group PLANETAS study

Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases

The global burden of IBD: from 2015 to 2025

An investigation into the relationship between climate change anxiety and mental health among Gen Z Filipinos

The biosimilar road in inflammatory bowel disease: The right way?

Science Mapping of the Global Knowledge Base on Management, Leadership, and Administration Related to COVID-19 for Promoting the Sustainability of Scientific Research

Climate change concerns impact on young Australians’ psychological distress and outlook for the future

Review article: pharmacological aspects of anti-TNF biosimilars in inflammatory bowel diseases

Examining Teachers’ Perspectives on School Principals’ Digital Leadership Roles and Technology Capabilities during the COVID-19 Pandemic

Explainable Artificial Intelligence (XAI): What we know and what is left to attain Trustworthy Artificial Intelligence

Biopharmaceuticals: Reference Products and Biosimilars to Treat Inflammatory Diseases

A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study

IFN-α kinoid in systemic lupus erythematosus: results from a phase IIb, randomised, placebo-controlled study

Impact of the COVID-19 Pandemic on Physical and Mental Health in Lower and Upper Middle-Income Asian Countries: A Comparison Between the Philippines and China

Psychological impact of COVID-19 pandemic in the Philippines

<p>Psychological State and Associated Factors During the 2019 Coronavirus Disease (COVID-19) Pandemic Among Filipinos with Rheumatoid Arthritis or Systemic Lupus Erythematosus</p>

FRI0143 A randomized, double-blind, phase 3 study demonstrates clinical equivalence of CT-P13 to infliximab when co-administered with methotrexate in patients with active rheumatoid arthritis